Yoshihiro Horii
- Neurology top 5%
- Neuroblastoma Research and Treatments 16
- Cell Biology top 10%
- Clinical Biochemistry top 10%
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cancer, Hypoxia, and Metabolism 4
-
- Virus-based gene therapy research 4
-
- Drug Transport and Resistance Mechanisms 3
-
- Sarcoma Diagnosis and Treatment 3
-
- interferon and immune responses 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- T MikiKazushige SakaguchiJohn F. BeelerM. TachibanaTohru SugimotoTadashi SawadaT. SawadaHiroshi Kuroda
- Journals
- International Journal of Cancer (6 papers)Journal of Veterinary Pharmacology and Therapeutics (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
Yoshihiro Horii
32 papers receiving 724 citations
Peers
Comparison fields: 5 of 77
- Neurology 251
- Cell Biology 146
- Clinical Biochemistry 46
- Molecular Biology 434
- Cancer Research 74
Countries citing papers authored by Yoshihiro Horii
This map shows the geographic impact of Yoshihiro Horii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Horii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Horii more than expected).
Fields of papers citing papers by Yoshihiro Horii
This network shows the impact of papers produced by Yoshihiro Horii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Horii. The network helps show where Yoshihiro Horii may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshihiro Horii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 15 | |
| 2 | 2004 | 26 | |
| 3 | 2002 | 43 | |
| 4 | 2001 | 18 | |
| 5 | 2001 | 16 | |
| 6 | 2001 | 36 | |
| 7 | 2000 | 11 | |
| 8 | 1999 | 30 | |
| 9 | 1998 | 3 | |
| 10 | [Basic calponin expressing human neuroblastoma cell line of KP-N-YS]. | 1998 | 1 |
| 11 | 1997 | 10 | |
| 12 | 1991 | 36 | |
| 13 | 1990 | 20 | |
| 14 | 1989 | 8 | |
| 15 | 1989 | 18 | |
| 16 | 1989 | 11 | |
| 17 | Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. | 1989 | 33 |
| 18 | 1988 | 13 | |
| 19 | 1987 | 2 | |
| 20 | Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. | 1986 | 32 |
About Yoshihiro Horii
Yoshihiro Horii is a scholar working on Neurology, Cancer Research, Cell Biology, Oncology and Genetics, having authored 32 papers that have together received 739 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (16 papers), Virus-based gene therapy research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Sarcoma Diagnosis and Treatment (3 papers), interferon and immune responses (2 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Neurology (251 citations), Cell Biology (146 citations), Clinical Biochemistry (46 citations), Molecular Biology (434 citations) and Cancer Research (74 citations). Yoshihiro Horii has collaborated with scholars based in Japan, United States and India. Frequent co-authors include T Miki, Kazushige Sakaguchi, John F. Beeler, M. Tachibana, Tohru Sugimoto, Tadashi Sawada, T. Sawada, Hiroshi Kuroda, Hiroyuki Morioka and Takafumi Matsumura. Their work appears in journals such as International Journal of Cancer, Journal of Veterinary Pharmacology and Therapeutics, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, The EMBO Journal and Diagnostic Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.